Methodology for the MASCC/ISOO Mucositis Clinical Practice Guidelines Update

Area of Science:

• Oncology
• Supportive Care
• Clinical Practice Guidelines

Background:

• Mucositis is a common and debilitating side effect of cancer therapy.
• Previous MASCC/ISOO guidelines were published in 2004 and updated in 2007.
• An updated systematic review was conducted in 2011 to inform new guidelines.

Purpose of the Study:

• To systematically review evidence on interventions for mucositis prevention and treatment.
• To update the MASCC/ISOO Clinical Practice Guidelines for mucositis management.
• To provide clinicians with objective, evidence-based recommendations.

Main Methods:

• Systematic review of interventions for mucositis.
• Development of updated clinical practice guidelines based on the review.
• Involvement of the Mucositis Study Group of MASCC/ISOO.

Main Results:

• The study resulted in updated clinical practice guidelines for mucositis.
• The guidelines are based on the latest available evidence from a 2011 systematic review.
• Recommendations focus on the prevention and treatment of mucositis.

Conclusions:

• Updated MASCC/ISOO guidelines provide evidence-based recommendations for mucositis management.
• These guidelines support clinicians in addressing mucositis secondary to cancer therapy.
• The update ensures current best practices for mucositis prevention and treatment are available.